Page last updated: 2024-08-23

cefotetan and HIV Coinfection

cefotetan has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cohen, CR; Gichuhi, JW; Kiehlbauch, JA; Meier, A; Mugo, NR; Nguti, R; Stamm, WE	1

Other Studies

1 other study(ies) available for cefotetan and HIV Coinfection

Article	Year
Effect of human immunodeficiency virus-1 infection on treatment outcome of acute salpingitis. Obstetrics and gynecology, 2006, Volume: 107, Issue:4 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Case-Control Studies; Cefotetan; Dose-Response Relationship, Drug; Doxycycline; Drug Administration Schedule; Female; Follow-Up Studies; HIV Infections; HIV Seronegativity; HIV Seropositivity; Humans; Injections, Intravenous; Laparoscopy; Length of Stay; Pelvic Inflammatory Disease; Prevalence; Probability; Prospective Studies; Risk Assessment; Salpingitis; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome	2006

Article

Year

Effect of human immunodeficiency virus-1 infection on treatment outcome of acute salpingitis.

Obstetrics and gynecology, 2006, Volume: 107, Issue:4

Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Case-Control Studies; Cefotetan; Dose-Response Relationship, Drug; Doxycycline; Drug Administration Schedule; Female; Follow-Up Studies; HIV Infections; HIV Seronegativity; HIV Seropositivity; Humans; Injections, Intravenous; Laparoscopy; Length of Stay; Pelvic Inflammatory Disease; Prevalence; Probability; Prospective Studies; Risk Assessment; Salpingitis; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome

2006